$ProShares UltraPro QQQ(TQQQ)$ This 45° vertical rally isn't retail-driven—it's the US going all-in on markets! National strength boosting financial data. Remaining bullish, let the momentum run!
$SharpLink Gaming(SBET)$ September 9: SharpLink Gaming disclosed it has begun a $1.5 billion stock buyback, repurchasing ~1 million SBET shares. The company believes the stock is deeply undervalued and expects the buyback to boost NAV and compound long-term shareholder value.
$YZJ Shipbldg SGD(BS6.SI)$ shipping those gains! Small win now but with global ship orders rebounding and LNG vessel boom, this baby's just getting started. SGX account making moves!
$Direxion Daily TSLA Bull 2X Shares(TSLL)$ 's modest gains - 2x leverage on $Tesla Motors(TSLA)$ 's volatility sure spices things up. But leveraged ETFs aren't for the faint-hearted. Taking profits here, maybe reload before next earnings. Slow and steady wins the race!
$Amazon.com(AMZN)$ Boom! $Wal-Mart(WMT)$ and Amazon are reportedly planning to launch their own stablecoins in the U.S., aiming to bypass $Visa(V)$ and $MasterCard(MA)$ . This is no small move, it could shake up the entire payment industry. Tough times ahead for the traditional giants.
$ProShares UltraPro Short Russell 2000(SRTY)$ I knew my operation was correct. I really admired my vision. I saw the situation clearly at the critical moment and acted quickly, accurately and ruthlessly. The money ran into my pocket by itself, hahahaha.
$J&T EXPRESS-W(01519)$ is on my radar for its strategic layout. The cost per delivery continues to drop, and its market share keeps expanding. The hub and spoke system is well-organized, and their international expansion is looking strong. Now, let’s see what kind of magic Li Jie will work next. I’m still bullish and keeping my bet on it!
$Zai Lab Ltd(ZLAB)$ The beauty of investing in innovative pharmaceuticals lies in the rewards of patience and conviction. In just one year, Zai Lab's stock has tripled despite experiencing multiple major pullbacks, each offering new opportunities. Now, with the NMPA officially accepting the BLA application for its breakthrough drug, Tisotumab Vedotin, This is not only an important milestone for the company, but also the highlight moment I have been looking forward to for a long time.